Table 2.
Overview of treatment
| Ipilimumab 3 mg/kg | Patients, n (%) |
|---|---|
| 1 dose | 6 (12%) |
| 2 doses | 3 (6%) |
| 3 doses | 6 (12%) |
| 4 doses | 35 (70%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.